10-May-24 08:00
Ching Chee Pun, Executive Chairman, Sunzen Biotech Berhad
It was announced that Sunzen Biotech will be exiting from its animal health business to focus on human health products and loan financing services. Executive chairman, Ching Chee Pun shares with us the rationale behind this decision, the outlook and why they appear to have a weak track record when it comes to M&A.
Chart | Stock Name | Last | Change | Volume |
---|
Created by Tan KW | Nov 21, 2024